Increased Cul1 expression promotes melanoma cell proliferation through regulating p27 expression.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  International Journal of Oncology

• Publication date

  2010-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/IJO_00000786PMID 20878082
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The tumor suppressor ING3 is degraded by SCFSkp2-mediated ubiquitin–proteasome system

  2010cited by this paper
• Targeting proteins for degradation.

  2009cited by this paper
• Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP: tipping the scales of cancer

  2008cited by this paper
• A functional link between Wnt signaling and SKP2-independent p27 turnover in mammary tumors.

  2008cited by this paper
• Current management of metastatic melanoma.

  2008cited by this paper
• Cyclin-dependent kinases and cell-cycle transitions: does one fit all?

  2008cited by this paper
• Dysfunction of the ubiquitin–proteasome system in multiple disease conditions: therapeutic approaches

  2008cited by this paper
• Cutaneous ultraviolet exposure and its relationship to the development of skin cancer.

  2008cited by this paper
• Knockdown of Skp2 by siRNA inhibits melanoma cell growth in vitro and in vivo.

  2006cited by this paper
• Cul4A and DDB1 Associate with Skp2 To Target p27Kip1 for Proteolysis Involving the COP9 Signalosome

  2006cited by this paper
• Ubiquitin ligases: cell-cycle control and cancer

  2006cited by this paper
• Involvement of CUL4 Ubiquitin E3 Ligases in Regulating CDK Inhibitors Dacapo/p27Kip1 and Cyclin E Degradation

  2006cited by this paper
• The role of cell cycle regulatory proteins in the pathogenesis of melanoma

  2006cited by this paper
• Narrative Review: Protein Degradation and Human Diseases: The Ubiquitin Connection

  2006cited by this paper
• Expression of Skp2 and p27KIP1 in naevi and malignant melanoma of the skin and its relation to clinical outcome.

  2005cited by this paper
• Cul4A targets p27 for degradation and regulates proliferation, cell cycle exit, and differentiation during erythropoiesis.

  2005cited by this paper
• APC/C and SCF: controlling each other and the cell cycle.

  2004cited by this paper
• Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship *

  2004cited by this paper
• Regulators of G1 cyclin–dependent kinases and cancers

  2003cited by this paper
• Apoptosis and melanoma chemoresistance

  2003cited by this paper
• Ratchets and clocks: the cell cycle, ubiquitylation and protein turnover

  2003cited by this paper
• The epidemiology of skin cancer

  2002cited by this paper
• An intact NEDD8 pathway is required for Cullin‐dependent ubiquitylation in mammalian cells

  2002cited by this paper
• The effect of sunscreen on melanoma risk.

  2002cited by this paper
• Focus on melanoma.

  2002cited by this paper
• The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction.

  2002cited by this paper
• Systemic chemotherapy for the treatment of metastatic melanoma.

  2002cited by this paper
• Expression of Skp2, a p27(Kip1) ubiquitin ligase, in malignant lymphoma: correlation with p27(Kip1) and proliferation index.

  2002cited by this paper
• Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.

  2001cited by this paper
• Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression.

  2000cited by this paper
• Loss of Cul1 results in early embryonic lethality and dysregulation of cyclin E

  1999cited by this paper
• p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27.

  1999cited by this paper
• SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27

  1999cited by this paper
• Chemotherapy-induced apoptosis in melanoma cells is p53 dependent

  1998cited by this paper
• The incidence of malignant melanoma in the United States: issues as we approach the 21st century.

  1996cited by this paper
• The ubiquitin-proteasome proteolytic pathway.

  1994cited by this paper

• The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer

  2024cites this paper
• Significant role and the underly mechanism of cullin-1 in chronic obstructive pulmonary disease

  2024cites this paper
• What have genetic studies of rare sequence variants taught us about the aetiology of schizophrenia?

  2024cites this paper
• The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer

  2023cites this paper
• RNF126, 168 and CUL1: The Potential Utilization of Multi-Functional E3 Ubiquitin Ligases in Genome Maintenance for Cancer Therapy

  2023cites this paper
• Computational drug repositioning identifies statins as a modifier of prognostic genetic expression signatures and metastatic behavior in melanoma.

  2021cites this paper
• A Comprehensive Assessment of Genetic and Epigenetic Alterations Identifies Frequent Variations Impacting Six Prototypic SCF Complex Members

  2021cites this paper
• The Skp2 Pathway: A Critical Target for Cancer Therapy.

  2020cites this paper
• Binimetinib, a novel MEK1/2 inhibitor, exerts anti-leukemic effects under inactive status of PI3Kinase/Akt pathway

  2019cites this paper
• CUL1 Knockdown Attenuates the Adhesion, Invasion, and Migration of Triple-Negative Breast Cancer Cells via Inhibition of Epithelial-Mesenchymal Transition

  2019cites this paper
• Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, combined with azacitidine in patients with AML.

  2018cites this paper
• Cullin-1 and -2 Protein Expression in Colorectal Cancer: Correlation with Clinicopathological Variables.

  2018cites this paper
• Cullin1 represses systematic inflammasome activation by binding and catalyzing NLRP3 ubiquitination

  2018cites this paper
• Synergistic role of Cul1 and c-Myc: Prognostic and predictive biomarkers in colorectal cancer.

  2017cites this paper
• A novel anti-mitotic activity on human cells by Pulchelloid A, a compound isolated from the prairie plant Gaillardia aristata

  2017cites this paper
• SENP8 limits aberrant neddylation of NEDD8 pathway components to promote cullin-RING ubiquitin ligase function

  2017cites this paper
• Upregulation of miR-223 in the rat liver inhibits proliferation of hepatocytes under simulated microgravity

  2017cites this paper
• Cul1 promotes melanoma cell proliferation by promoting DEPTOR degradation and enhancing cap-dependent translation.

  2016cites this paper
• Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells

  2016cites this paper
• Pharmacogenomics and chemical library screens reveal a novel SCFSKP2 inhibitor that overcomes Bortezomib resistance in multiple myeloma

  2016cites this paper
• Reduced cullin 1 expression enhances the effects of fluorouracil-leucovorin-oxaliplatin in resectable gastric cancer

  2016cites this paper
• The expression of Cullin1 is increased in renal cell carcinoma and promotes cancer cell proliferation, migration, and invasion

  2016cites this paper
• Role of E3 ubiquitin ligases in gastric cancer.

  2015cites this paper
• Cullin1 is a novel prognostic marker and regulates the cell proliferation and metastasis in colorectal cancer

  2015cites this paper
• E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma.

  2015cites this paper
• Cullin1 is up-regulated and associated with poor patients' survival in hepatocellular carcinoma.

  2015cites this paper
• Pevonedistat (MLN4924), a First‐in‐Class NEDD8‐activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 study

  2015cites this paper
• Skp1 in lung cancer: clinical significance and therapeutic efficacy of its small molecule inhibitors

  2015cites this paper
• High expression of Cullin1 indicates poor prognosis for NSCLC patients.

  2014cites this paper
• Aberrant Expression Pattern and Location of Cullin 1 are Associated With the Development of Papillary Carcinoma in Thyroid and Cyclin D1 Expression

  2014cites this paper
• MEK inhibitor effective against proliferation in breast cancer cell

  2014cites this paper
• Cullin1 is a novel marker of poor prognosis and a potential therapeutic target in human breast cancer.

  2013cites this paper
• Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer.

  2013cites this paper
• Systems biology of Ewing sarcoma: a network model of EWS-FLI1 effect on proliferation and apoptosis

  2013cites this paper
• Deregulation of the COP9 signalosome-cullin-RING ubiquitin-ligase pathway: mechanisms and roles in urological cancers.

  2013cites this paper
• Role of Tip60 in human melanoma cell migration, metastasis, and patient survival.

  2012cites this paper
• Novel Multiple Markers to Distinguish Melanoma from Dysplastic Nevi

  2012cites this paper
• Diagnostic and prognostic relevance of Cullin1 expression in invasive ductal carcinoma of the breast

  2012cites this paper
• Ring finger protein 146/Iduna is a Poly(ADP-ribose) polymer binding and PARsylation dependent E3 ubiquitin ligase

  2011cites this paper
• Cytoplasmic Skp2 Expression Is Increased in Human Melanoma and Correlated with Patient Survival

  2011cites this paper